Redeye raises its Base and Bull Cases and its forecasts, following a Q3 report beating our estimates. While we expect operational momentum to continue, our Base Case remains below the current share price due to our conservative take on 2030 and onwards. However, assuming a stable development post-2030, our Bull Case takes a more optimistic approach.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Hexatronic - Expanding in the US

© Modular Finance, source Nordic Press Releases